We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
PTC Therapeutics Inc | NASDAQ:PTCT | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 34.16 | 33.88 | 34.83 | 0 | 01:00:00 |
Delaware
|
|
001-35969
|
|
04-3416587
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
100 Corporate Court
|
|
|
South Plainfield, NJ
|
|
07080
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Director
|
|
For
|
|
Withheld
|
|
Broker
Non-Votes
|
|
Stuart W. Peltz, Ph.D.
|
|
29,043,013
|
|
75,347
|
|
5,544,983
|
|
Jerome B. Zeldis, M.D., Ph.D.
|
|
21,653,839
|
|
7,464,521
|
|
5,544,983
|
|
|
PTC Therapeutics, Inc.
|
|||
|
|
|||
Date: June 12, 2017
|
By:
|
/s/ Christine Utter
|
|
|
|
Name:
|
Christine Utter
|
||
|
Title:
|
Principal Financial Officer
|
1 Year PTC Therapeutics Chart |
1 Month PTC Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions